Moreover, IKBKE overexpression was associated with late stage, high grade, poor prognosis, and resistance to cisplatin, all of which suggested that IKBKE was a critical mediator of ovarian cancer progression and drug resistance. The gene discussed is IKBKE; the disease is ovarian carcinoma.